Dr. Borg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
971 Lakeland Drive
Suite 1159
Jackson, MS 39216Phone+1 769-251-5674Fax+1 769-243-8130- Is this information wrong?
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Gastroenterology, 2006 - 2009
- Clinical Center at the National Institutes of HealthFellowship, Transplant Hepatology, 2003 - 2006
- University of Maryland Capital Region HealthResidency, Internal Medicine, 2000 - 2003
- Tehran University of Medical Sciences School of MedicineClass of 1992
Certifications & Licensure
- LA State Medical License 2009 - 2025
- MO State Medical License 2023 - 2025
- MS State Medical License 2012 - 2024
- KS State Medical License 2023 - 2024
- MD State Medical License 2003 - 2018
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Clinical Trials
- Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure Start of enrollment: 2013 Feb 01
- Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis Start of enrollment: 2014 Dec 26
- Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis Start of enrollment: 2015 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsOpen-label, clinical trial extension: Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis.Marlyn J Mayo, John M Vierling, Christopher L Bowlus, Cynthia Levy, Gideon M Hirschfield, Guy W Neff, Michael R Galambos, Stuart C Gordon, Brian B Borg, Stephen A Harr...> ;Alimentary Pharmacology & Therapeutics. 2024 Jan 1
- 26 citationsAldafermin in patients with non-alcoholic steatohepatitis (ALPINE 2/3): a randomised, double-blind, placebo-controlled, phase 2b trial.Stephen A Harrison, Manal F Abdelmalek, Guy Neff, Nadege Gunn, Cynthia D Guy, Naim Alkhouri, Mustafa R Bashir, Bradley Freilich, Anita Kohli, Arun Khazanchi, Muhammad ...> ;The Lancet. Gastroenterology & Hepatology. 2022 Jul 1
- 32 citationsA Phase 2 Double Blinded, Randomized Controlled Trial of Saroglitazar in Patients with Nonalcoholic Steatohepatitis.Mohammad S. Siddiqui, Michael O. Idowu, Deven Parmar, Brian B. Borg, Douglas Denham, Nicole M. Loo, Donald Lazas, Ziad Younes, Arun J. Sanyal> ;Clinical Gastroenterology and Hepatology. 2021 Dec 1
- Join now to see all
Hospital Affiliations
- University of Mississippi Medical CenterJackson, Mississippi
- G.V. (Sonny) Montgomery Department of Veterans Affairs Medical CenterJackson, Mississippi
- St. Dominic-Jackson Memorial HospitalJackson, Mississippi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: